Mitochondria are implicated in amyotrophic lateral sclerosis. This preprint asks which mitochondrial pathways carry inherited risk, and whether the same pathways are a cause of disease or a consequence of it.
The authors tested pathways from the MitoCarta3.0 mitochondrial gene inventory against the largest European genome-wide association study they cite, 27,205 people with ALS and 110,881 people without. Of seven broad categories, only the mitochondrial central dogma remained enriched after correction, with an adjusted P of 0.044. Inside that category, the signal localized to mitochondrial translation (adjusted P 0.008) and the mitoribosome (adjusted P 0.014).
The direction was not one-way. Genetically predicted expression associated higher risk with lower MRPS33, a small-subunit mitochondrial ribosomal protein, and with higher MRPL28, a large-subunit protein. Those genetic directions did not agree with expression changes in ALS tissue more often than chance.
In post-mortem motor cortex from two cohorts, mitochondrial genes were broadly higher in ALS, largely as a global shift. Oxidative phosphorylation subunits and the mitoribosome rose beyond that shift in one consortium's motor cortex (both false-discovery rates 0.027). Oxidative phosphorylation subunits were also enriched in motor neurons made from induced pluripotent stem cells (false-discovery rate 2.4e-8). Spinal cord showed no genome-wide enrichment. A nominal link between an expression cluster and survival in lumbar spinal cord (unadjusted P 0.013) did not leave any single pathway associated with survival after correction.
A nominal enrichment for reactive oxygen species and glutathione metabolism was largely SOD1, superoxide dismutase 1. The abstract does not measure copper or zinc at that enzyme. In post-mortem tissue, nuclear-encoded mitochondrial genes were more negatively co-expressed with genes encoded by mitochondrial DNA than in controls, most strongly in lumbar spinal cord. Stem-cell motor neurons showed the opposite co-expression pattern.
Metal and redox
No iron-sulfur cluster is reported. The only redox gene the abstract isolates is SOD1, and it isolates that gene as the weight behind a nominal glutathione and reactive-oxygen enrichment. That is a genetic attribution, not a measurement of superoxide or of the copper and zinc sites.
What this does not show
Inherited risk and end-stage expression are different observations, and the abstract says they do not line up. Higher oxidative phosphorylation transcripts in dying tissue can be a response, a change in which cells are present, or both. This is a preprint read from the abstract. It is not a mechanism of toxicity and not a treatment claim.
